Demonstration dataset

The data shown here is synthetic. It demonstrates how a future anonymised lived-experience observatory could work. These figures are not medical statistics and must not be interpreted as evidence about any medication.

Observatory

What becomes visible when treatment episodes are structured.

Filters reshape a fictional cohort. Every chart shows its sample size. Reports are not incidence. Association is not causality.

Treatment episodes in view: 1920 of 1,920 synthetic records

Treatment episode count by ADHD medicine

n = 1920

methylphenidate458 · 24%
lisdexamfetamine501 · 26%
dexamfetamine477 · 25%
none484 · 25%

Treatment episode count by ADHD medicine table
Category	Count
methylphenidate	458
lisdexamfetamine	501
dexamfetamine	477
none	484

Concurrent antidepressant

n = 1920

none379 · 20%
venlafaxine411 · 21%
fluoxetine354 · 18%
sertraline385 · 20%
escitalopram391 · 20%

Concurrent antidepressant table
Category	Count
none	379
venlafaxine	411
fluoxetine	354
sertraline	385
escitalopram	391

Before sleep distribution (hours, complete cases)

n = 1563

3–4h0 · 0%
4–5h0 · 0%
5–6h0 · 0%
6–7h520 · 33%
7–8h711 · 45%
8–9h332 · 21%
9–10h0 · 0%

Before sleep distribution (hours, complete cases) table
Category	Count
3–4h	0
4–5h	0
5–6h	0
6–7h	520
7–8h	711
8–9h	332
9–10h	0

After sleep distribution (hours, complete cases)

n = 1563

3–4h0 · 0%
4–5h52 · 3%
5–6h391 · 25%
6–7h605 · 39%
7–8h415 · 27%
8–9h99 · 6%
9–10h1 · 0%

After sleep distribution (hours, complete cases) table
Category	Count
3–4h	0
4–5h	52
5–6h	391
6–7h	605
7–8h	415
8–9h	99
9–10h	1

Reported improvements (6 tracked; counts are reports, not incidence)

n = 1920

cognitive noise731 · 38%
task initiation436 · 23%
focus758 · 39%
emotional regulation464 · 24%
calm478 · 25%
working memory469 · 24%

Reported improvements (6 tracked; counts are reports, not incidence) table
Category	Count
cognitive noise	731
task initiation	436
focus	758
emotional regulation	464
calm	478
working memory	469

Reported adverse experiences from 1920 episodes — not a rate of harm

n = 1920

insomnia499 · 26%
appetite reduction600 · 31%
anxiety237 · 12%
irritability149 · 8%
headache148 · 8%
activation165 · 9%
low mood145 · 8%
sensory intensity150 · 8%

Reported adverse experiences from 1920 episodes — not a rate of harm table
Category	Count
insomnia	499
appetite reduction	600
anxiety	237
irritability	149
headache	148
activation	165
low mood	145
sensory intensity	150

Experience onset relative to medication change

n = 1358

Before0 · 0%
Day 0–3260 · 19%
Day 4–7256 · 19%
Day 8–14463 · 34%
Day 15+379 · 28%

Experience onset relative to medication change table
Category	Count
Before	0
Day 0–3	260
Day 4–7	256
Day 8–14	463
Day 15+	379

Experience onset relative to sleep change

n = 1045

Before213 · 20%
Day 0–3290 · 28%
Day 4–7299 · 29%
Day 8–14243 · 23%
Day 15+0 · 0%

Experience onset relative to sleep change table
Category	Count
Before	213
Day 0–3	290
Day 4–7	299
Day 8–14	243
Day 15+	0

Interoceptive awareness change (complete cases)

n = 1403

Much less clear196 · 14%
Slightly less181 · 13%
No change283 · 20%
Slightly more418 · 30%
Much more clear325 · 23%

Interoceptive awareness change (complete cases) table
Category	Count
Much less clear	196
Slightly less	181
No change	283
Slightly more	418
Much more clear	325

Missing data indicator

n = 1920

Sleep complete1563 · 81%
Sleep missing357 · 19%
Body-awareness complete1403 · 73%
Body-awareness missing517 · 27%

Missing data indicator table
Category	Count
Sleep complete	1563
Sleep missing	357
Body-awareness complete	1403
Body-awareness missing	517

Concurrent medication changes

n = 1920

Concurrent change recorded669 · 35%
No concurrent change recorded1251 · 65%

Concurrent medication changes table
Category	Count
Concurrent change recorded	669
No concurrent change recorded	1251

Simultaneous antidepressant taper

n = 1920

Taper overlapping stimulant start440 · 23%
No overlapping taper1480 · 77%

Simultaneous antidepressant taper table
Category	Count
Taper overlapping stimulant start	440
No overlapping taper	1480

Contribute anonymised observations is a future action, completely separate from personal tracking. Using the timeline is not consent to research.